Movano Inc. (MOVE)
USD 1.19
(-11.19%)
USD 1.19
(-11.19%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 29.69 Million USD | -2.53% |
| 2022 | 30.46 Million USD | 53.83% |
| 2021 | 19.8 Million USD | 78.29% |
| 2020 | 11.1 Million USD | 30.49% |
| 2019 | 8.51 Million USD | 143.69% |
| 2018 | 3.49 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 5.39 Million USD | -9.91% |
| 2024 Q2 | 6.01 Million USD | 11.61% |
| 2023 Q3 | 9.07 Million USD | 22.96% |
| 2023 FY | 29.53 Million USD | -3.05% |
| 2023 Q4 | 5.98 Million USD | -34.09% |
| 2023 Q2 | 7.38 Million USD | 2.51% |
| 2023 Q1 | 7.2 Million USD | -10.2% |
| 2022 Q3 | 8.65 Million USD | 26.45% |
| 2022 Q2 | 6.84 Million USD | -1.33% |
| 2022 Q1 | 6.93 Million USD | 9.92% |
| 2022 FY | 30.46 Million USD | 53.83% |
| 2022 Q4 | 8.02 Million USD | -7.35% |
| 2021 Q1 | 3.26 Million USD | 3.03% |
| 2021 Q2 | 5.04 Million USD | 54.5% |
| 2021 FY | 19.8 Million USD | 78.29% |
| 2021 Q4 | 6.31 Million USD | 21.88% |
| 2021 Q3 | 5.17 Million USD | 2.64% |
| 2020 Q2 | 2.73 Million USD | 35.46% |
| 2020 FY | 11.1 Million USD | 30.49% |
| 2020 Q4 | 3.17 Million USD | -0.41% |
| 2020 Q3 | 3.18 Million USD | 16.38% |
| 2020 Q1 | 2.01 Million USD | -13.72% |
| 2019 FY | 8.51 Million USD | 143.69% |
| 2019 Q4 | 2.34 Million USD | 0.0% |
| 2018 FY | 3.49 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 47.524% |
| BrainsWay Ltd. | 28.01 Million USD | -5.968% |
| Cerus Corporation | 143.15 Million USD | 79.26% |
| Envoy Medical, Inc. | 17.89 Million USD | -65.884% |
| electroCore, Inc. | 32.03 Million USD | 7.309% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -137.729% |
| IceCure Medical Ltd | 16.87 Million USD | -75.93% |
| Inogen, Inc. | 236.08 Million USD | 87.424% |
| OrthoPediatrics Corp. | 137.01 Million USD | 78.331% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 30.029% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -68.377% |
| MaxCyte, Inc. | 84.84 Million USD | 65.007% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -139.208% |
| Nexalin Technology, Inc. | 5.78 Million USD | -413.547% |
| Orthofix Medical Inc. | 667.42 Million USD | 95.552% |
| PAVmed Inc | 64.82 Million USD | 54.201% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 41.873% |
| RxSight, Inc. | 103.85 Million USD | 71.411% |
| Sight Sciences, Inc. | 126.44 Million USD | 76.52% |
| SI-BONE, Inc. | 156.35 Million USD | 81.011% |
| TELA Bio, Inc. | 84.18 Million USD | 64.733% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 85.401% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -19.017% |
| Acutus Medical, Inc. | 11.22 Million USD | -164.522% |
| Talis Biomedical Corporation | 67.18 Million USD | 55.809% |
| Spectral AI, Inc. | 20.86 Million USD | -42.303% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 46.979% |
| CVRx, Inc. | 76.14 Million USD | 61.007% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -741.554% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -161.336% |
| Bioventus Inc. | 409.91 Million USD | 92.757% |
| Venus Concept Inc. | 80.47 Million USD | 63.107% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 57.62% |
| LivaNova PLC | 843.54 Million USD | 96.48% |
| 908 Devices Inc. | 68.08 Million USD | 56.39% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 93.861% |
| Nemaura Medical Inc. | 7.13 Million USD | -315.896% |
| NeuroPace, Inc. | 75.29 Million USD | 60.569% |
| LENSAR, Inc. | 33.33 Million USD | 10.937% |
| Apyx Medical Corporation | 51.01 Million USD | 41.805% |
| Cutera, Inc. | 197.72 Million USD | 84.984% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -19.81% |
| BioSig Technologies, Inc. | 28.53 Million USD | -4.066% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 84.494% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 17.665% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 96.45% |
| Axonics, Inc. | 270.2 Million USD | 89.012% |
| Outset Medical, Inc. | 198.77 Million USD | 85.063% |
| IRIDEX Corporation | 31.81 Million USD | 6.676% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 83.526% |
| IRadimed Corporation | 30.12 Million USD | 1.437% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -247.984% |
| INVO Bioscience, Inc. | 7.85 Million USD | -278.058% |
| Telesis Bio, Inc. | 63.48 Million USD | 53.236% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 69.843% |
| Varex Imaging Corporation | 224.8 Million USD | 86.793% |
| Quipt Home Medical Corp. | 148.66 Million USD | 80.029% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -153.263% |
| Pulmonx Corporation | 112.68 Million USD | 73.653% |
| Dynatronics Corporation | 9.9 Million USD | -199.656% |
| Modular Medical, Inc. | 17.52 Million USD | -69.376% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -47.075% |
| Semler Scientific, Inc. | 38.94 Million USD | 23.762% |
| InMode Ltd. | 215.68 Million USD | 86.234% |
| Bruker Corporation | 1.07 Billion USD | 97.242% |
| Cytosorbents Corporation | 48.33 Million USD | 38.577% |
| DexCom, Inc. | 1.69 Billion USD | 98.244% |
| Align Technology, Inc. | 2.07 Billion USD | 98.57% |
| Viveve Medical, Inc. | 22.17 Million USD | -33.902% |
| ZimVie Inc. | 275.12 Million USD | 89.209% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 78.371% |
| Nexalin Technology, Inc. | 5.78 Million USD | -413.547% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -741.554% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 95.059% |
| Profound Medical Corp. | 33.6 Million USD | 11.645% |
| Insulet Corporation | 939.9 Million USD | 96.841% |
| enVVeno Medical Corporation | 25.23 Million USD | -17.64% |
| Surmodics, Inc. | 98.69 Million USD | 69.918% |
| iCAD, Inc. | 22.22 Million USD | -33.588% |
| Nuwellis, Inc. | 22.61 Million USD | -31.296% |
| Biotricity, Inc. | 17.18 Million USD | -72.771% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 93.341% |
| Aethlon Medical, Inc. | 12.27 Million USD | -141.824% |
| InspireMD, Inc. | 22.95 Million USD | -29.368% |
| PAVmed Inc. | 64.82 Million USD | 54.201% |
| BIOLASE, Inc. | 34.66 Million USD | 14.342% |
| Beyond Air, Inc. | 61.7 Million USD | 51.88% |
| FONAR Corporation | 28.6 Million USD | -3.794% |
| AxoGen, Inc. | 149.33 Million USD | 80.119% |
| Vivani Medical, Inc. | 26.96 Million USD | -10.106% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 83.235% |
| Inari Medical, Inc. | 448.59 Million USD | 93.382% |
| UFP Technologies, Inc. | 58.08 Million USD | 48.889% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -502.525% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -369.906% |
| Tenon Medical, Inc. | 16.96 Million USD | -74.976% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -301.596% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 32.68% |
| AdaptHealth Corp. | 1.07 Billion USD | 97.246% |
| Sintx Technologies, Inc. | 15.2 Million USD | -95.316% |
| NanoVibronix, Inc. | 4.97 Million USD | -497.024% |
| Quanterix Corporation | 118.1 Million USD | 74.86% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -153.263% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -105.581% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 92.439% |
| TransMedics Group, Inc. | 182.82 Million USD | 83.76% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -5.79% |
| NeuroMetrix, Inc. | 11.09 Million USD | -167.503% |
| Hyperfine, Inc. | 52.87 Million USD | 43.846% |
| Establishment Labs Holdings Inc. | 172 Million USD | 82.739% |
| Biomerica, Inc. | 6.97 Million USD | -325.48% |
| Bone Biologics Corporation | 9.42 Million USD | -214.903% |
| AVITA Medical, Inc. | 80.77 Million USD | 63.245% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -187.939% |
| Silk Road Medical, Inc | 186.35 Million USD | 84.068% |